Source: Pharmabiz

SK Biopharmaceuticals: SK Biopharmaceuticals inks research collaboration agreement with ProEn Therapeutics for radiopharmaceuticals

SK Biopharmaceuticals, a biotech company focusing on the research, development and commercialization of treatments for disorders of the central nervous system and oncology worldwide, announced a research collaboration

Read full article »
Annual Revenue
$100-500M
Employees
250-500
Donghoon Lee's photo - President & CEO of SK Biopharmaceuticals

President & CEO

Donghoon Lee

CEO Approval Rating

90/100

Read more